Centogene AG

Genes - Enzymes - Metabolites :: Diagnostics on all molecular and biochemical levels

Centogene was founded in 2006 and has since been dedicated to the highest quality genetic and biochemical diagnostic testing for the global medical community. We believe that the molecular understanding of rare disease allows for the coordination of personalized and focused therapy and improved control of rare and congenital disease. This is being supported by the development of very specific and sensitive biomarkers. As one of the world's leading companies in molecular diagnostics, we also support clinicians with expert genetic counseling services and newborn screening. We deliver solutions for your rare disease diagnostics on a laboratory scale.

Through the impressive research achievements of our highly qualified staff, molecular geneticists and our molecular diagnostic network, we are making huge contributions in the detection of disorders in patients from around the world. We believe that the best treatment to improve your patient's quality of life and disease state is early detection.

Centogene also collaborates with both academic and industrial partners on the development of new diagnostic techniques and orphan drugs.

We cooperate with Prof. Dr. Jürgen Kohlhase's  Center for Human Genetics in Freiburg, Germany.